Oyster Point Pharmaceuticals

Oyster Point Pharmaceuticals

A clinical stage pharmaceutical company focused on the discovery development & commercialization .

HQ location
San Francisco, United States
Launch date
Employees
Market cap
$300m
Enterprise value
$326m
Share price
$11.17 OYST
Authorizing premium user...